Black Bird Biotech, Inc. filed its 10-K on Apr 15, 2022 for the period ending Dec 31, 2021. In this report its auditor, Farmer, Fuqua & Huff, P.C. , gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | 0.00% |
04-16 | Black Bird Biotech, Inc. Appoints Nelson Grist as New CEO | CI |
04-16 | Black Bird Biotech, Inc. Appoints Nelson Grist as Its Future Member of Its Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 298K | |
+42.64% | 6.38B | |
-15.52% | 4.59B | |
+8.35% | 3.39B | |
-11.10% | 3.2B | |
-4.12% | 2.52B | |
+46.46% | 2B | |
-7.97% | 1.7B | |
-1.07% | 1.65B | |
-11.56% | 1.58B |
- Stock Market
- Equities
- BBBT Stock
- News Black Bird Biotech, Inc.
- Black Bird Biotech, Inc. Auditor Raises 'Going Concern' Doubt